ºÚÁÏÍø

Graduate student Orrin Stone is creating molecular tools to pinpoint how and when cellular pathways trigger cell movement – or, in cancer, metastasis.

On Wednesday, November 5, 2014, the Department of Pharmacology celebrated Dr. Bryan Roth’s election to the Institute of Medicine with a pizza party. Why pizza you may ask? Bryan likes pizza.

ºÚÁÏÍø Pharmacology & Toxicology Ranked #3 in the World by U.S. News & World Report

Joseph DeSimone, PhD, the Chancellor’s Eminent Professor of Chemistry and a joint Professor in the Department of Pharmacology, has been elected to the Institute of Medicine, one of the highest honors in the fields of health and medicine. This election represents the third time Desimone has been elected to a...

Roth’s research to create innovative tools for neuroscientists and discover potential targets for therapeutics has earned him one of the highest honors in the field of medicine.

Above photo: Ken with symposium speakers (L to R): Qisheng Zhang, Len Stephens, John Hepler, Ken, Alex Brown, Roger Sunahara and Eduardo Lazarowski. The Pharmacology department hosted a half-day symposium on October 21, 2014 honoring Professor T. Kendall Harden. Ken joined the Pharmacology department in 1977 as an Assistant Professor...

Led by Bryan L. Roth, MD, PhD, three ºÚÁÏÍø labs will develop the next generation neuroscience tool-kit to accelerate novel treatments for neuropsychiatric and a host of other diseases. ~by Mark Derewicz

Photo above (R to L) Ernesto with his mentor, Dr. Christian Jobin. Click for larger image. Ernesto Perez-Chanona, a member of the Jobin lab, successfully defended his dissertation September 18, 2014 and will officially receive his Ph.D. December 14, 2014 when he graduates. The title of his dissertation is “Microbial...

Drs. Bryan Roth and Gary Johnson receive 2 of 9 grants awarded by the NIH Illuminating the Druggable Genome Initiative which is supporting research to study 4 of the most commonly drug-targeted protein families

Zefeng Wang's paper published in Cancer Cell this week shows that the splicing factor RBM4 suppresses proliferation and migration of various cancer cells by specifically controlling cancer-related splicing.